Orchid Pharma Ltd share price logo

Orchid Pharma Share Price

NSE: ORCHPHARMA

BSE: 524372

Small Cap

Healthcare Sector

₹523.80

+4.50

(+0.87%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Orchid Pharma Stock Performance

as on April 2, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹498.10
    ₹526.40
    downward going graph

    4.91%

    Downside

    0.50%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹480.00
    ₹899.00
    downward going graph

    8.36%

    Downside

    71.63%

    Upside

    downward going graph

Orchid Pharma share price movements today

Previous Close
₹519.30
Open
₹511.55
Volume
1.21L
Upper Circuit
₹623.15
Lower Circuit
₹415.45
Day's Low - High
₹498.10 - ₹526.40
52 Week Low - High
₹480.00 - ₹899.00

Orchid Pharma Historical Returns

1 Month Return
-7.33 %
3 Month Return
-33.29 %
1 Year Return
-30.73 %
3 Year Return
+ 35.7 %
5 Year Return
-78.19 %

Orchid Pharma Fundamentals

as on April 2, 2026 at 4:01 pm IST

Market Cap

₹2,656.67 Cr

Return on Equity (ROE)

3.32

PE Ratio (TTM)

140.81

Return on capital employed (ROCE)

3.61

Industry PE ratio

40.5

Beta (LTM)

1.23

P/B Ratio

3.14

Dividend Yield

0

PEG Ratio

-7.67

Quarterly Earnings Growth YOY

-154.12

EPS (TTM)

18.88

Sector

Pharmaceuticals

Book Value

236.35

Technical Analysis

Bearish

View Technical Analysis

Orchid Pharma Stock Valuation

as on April 2, 2026 at 4:01 pm IST

Orchid Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-871.56x)

April 8, 2022

Industry (40.50x)

April 2, 2026

Today (140.81x)

April 2, 2026

Highest (213.62x)

January 2, 2026

LowHigh

Today’s Price to Earnings Ratio: 140.81x

Orchid Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Orchid Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Orchid Pharma Ltd image
Orchid Pharma Ltd
BUY2,656.67-15.64%0.5695921
Syschem (India) Ltd image
Syschem (India) Ltd
NA218.99105.33%0.002386
Shree Ganesh Biotech India Ltd image
Shree Ganesh Biotech India Ltd
NA23.92-17.95%0.00222
Supriya Lifescience Ltd image
Supriya Lifescience Ltd
BUY4,927.1611.33%0.00187696
Vivimed Labs Ltd image
Vivimed Labs Ltd
NA48.01-13.25%1.02-32116
See all

Market expectation of Orchid Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Orchid Pharma Stock’s Investor Sentiment and Interest

Search interest for Orchid Pharma Ltd Stock has increased by 27% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:27% versus previous 30 day period

Orchid Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Sales
182.92
198.76
220.59
217.1
244.41
222.7
217.34
237.48
172.93
193.52
207.27
Other Income
1.89
8.36
7.62
13.36
7.57
7.52
8.49
3.9
11.45
10.77
5.61
Total Income
184.81
207.11
228.21
230.46
251.98
230.22
225.83
241.38
184.38
204.3
212.88
Expenses
160.78
175.44
185.2
188.18
211.91
192.36
190.98
209.5
158.75
195
212.82
Operating Profit
22.14
23.32
35.39
28.92
32.5
30.34
26.36
27.98
14.18
-1.48
-5.55
Operating Profit Margin %
12.1%
11.73%
16.04%
13.32%
13.3%
13.62%
12.13%
11.78%
8.2%
-0.76%
-2.68%
Profit Before Interest, Tax and Depreciation
24.03
31.67
43.01
42.28
40.06
37.85
34.85
31.88
25.62
9.3
0.06
Interest
5.55
3.8
3.54
3.47
3.5
3.33
3.8
3.92
3.26
3.73
3.18
Depreciation
7.71
7.84
9.27
8.42
8.44
8.63
8.61
8.87
8.65
8.9
9.03
Profit Before Tax
10.77
20.03
30.2
30.39
28.12
25.89
22.44
19.09
13.71
-3.33
-12.15
Tax Paid
-
-
-
-3.12
-0.15
-
-
-0.04
-
-
-
Profit After Tax
10.78
20.02
30.19
33.5
28.27
25.9
22.45
19.13
13.71
-3.33
-12.15
Total Net profit including share of profit / Loss from associate company
9.41
19.8
29.43
32.95
29.35
27.24
20.78
22.29
14.91
-5.72
-12.62
EPS
1.85
4.3
6.18
6.81
5.79
5.37
4.1
4.4
2.94
-1.13
-2.49
Actual EPS
1.85
4.3
6.18
6.81
5.79
5.37
4.1
4.4
2.94
-1.13
-2.49
Adjusted EPS
1.85
4.3
6.18
6.81
5.79
5.37
4.1
4.4
2.94
-1.13
-2.49
Diluted EPS
1.85
4.3
6.18
6.81
5.79
5.37
4.1
4.4
2.94
-1.13
-2.49

Orchid Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
682.98
599.98
483.81
450.06
559.56
665.9
819.37
921.93
Other Income
20.3
217.86
24.28
15.23
67.47
58.64
30.86
27.47
Total Income
703.29
817.84
508.09
465.29
627.03
724.54
850.23
949.4
Expenses
667.29
618.19
517.03
421.56
506.42
589.06
708.69
804.75
Operating Profit
15.69
-18.21
-33.22
28.5
53.14
76.84
110.68
117.18
Operating Profit Margin %
2.3%
-3.04%
-6.87%
6.33%
9.5%
11.54%
13.51%
12.71%
Profit Before Interest, Tax and Depreciation
36
199.65
-8.94
43.72
120.61
135.48
141.54
144.65
Interest
301.65
0.3
4.16
51.34
32.01
32.23
16.35
14.54
Depreciation
133.31
129.94
117.93
108.92
87.02
54.79
33.24
34.55
Profit Before Tax
-398.96
69.41
-131.03
-116.54
1.58
48.46
91.95
95.56
Tax Paid
-46.19
-
-
-
-
-
-3.12
-0.19
Profit After Tax
-352.77
69.41
-131.03
-116.53
1.57
48.47
95.06
95.76
Total Net profit including share of profit / Loss from associate company
-352.77
69.41
-131.03
-116.53
-1.95
46.32
92.16
99.66
EPS
-39.65
7.8
-32.11
-28.55
-0.48
11.35
19.06
19.65
Actual EPS
-39.65
7.8
-32.11
-28.55
-0.48
11.35
19.06
19.65
Adjusted EPS
-39.65
7.8
-32.11
-28.55
-0.48
11.35
19.06
19.65
Diluted EPS
-39.65
7.8
-32.11
-28.55
-0.48
11.35
19.06
19.65

Orchid Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
212.2
400.95
9.18
12.02
80.8
23.59
92.47
18.34
125.99
19.22
Cash Flow from Investing Activities
-1.46
-175.95
-28.05
45.47
167.12
67.21
112.94
-31.2
-312.03
-26.93
Cash Flow from Financing Activities
-286.36
-465.19
33.39
-0.3
-250.34
-164.99
-216.8
31.16
167.03
25.23
Net Cash Flow
-75.62
-240.19
14.51
57.2
-2.42
-74.2
-11.39
18.29
-19
17.51

Orchid Pharma Stock Shareholding Pattern

Numbers in percentages

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Promoters
72.4%
72.4%
69.84%
69.84%
69.84%
69.84%
69.84%
69.84%
69.84%
69.84%
69.84%
DII
13.49%
9.88%
14.5%
17.73%
18.93%
18.29%
18.99%
20.1%
19.43%
19.04%
19.39%
FII
0%
0%
4.14%
1.96%
1.42%
1.94%
2.53%
2.69%
1.4%
1.56%
1.17%
Public
5.53%
7.06%
11.53%
10.47%
9.81%
9.93%
8.64%
7.38%
9.34%
9.57%
9.6%
Total Outstanding Shares
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
5,07,19,105
Total Shareholders
29,132
29,197
36,931
36,720
34,695
36,363
34,158
34,303
39,827
38,155
35,709

Mutual Funds that own Orchid Pharma Stock

Check out the Mutual Funds with significant holdings in Orchid Pharma.

Orchid Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Orchid Pharma.

  • Orchid Pharma Ltd Earnings Results

    Orchid Pharma Ltd’s net profit fell -160.68% since last year same period to ₹-12.61Cr in the Q3 2025-2026. On a quarterly growth basis, Orchid Pharma Ltd has generated -120.45% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Orchid Pharma Ltd Dividends May,2012

    In the quarter ending March 2012, Orchid Pharma Ltd has declared dividend of ₹3.00 per share on 15 May 2012 - translating a dividend yield of 1.15%.

    Read More about Dividends

Indices Featuring Orchid Pharma Stock

Check stock indices that include Orchid Pharma.

BSE Healthcare

₹41,371.63

-0.75 (▲312.71%)

Insights on Orchid Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 184.38 Cr → 212.88 Cr (in ₹), with an average increase of 6.9% per quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 9.57% to 9.60% in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Lupin Ltd has given 249.0% return, outperforming this stock by 213.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 69.84% of holdings in Dec 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 22.8% return, outperforming this stock by 57.0%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 18.04% to 18.01% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 1.56% to 1.17% in Dec 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ORCHPHARMA stock has moved down by -33.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 22.29 Cr → -12.61 Cr (in ₹), with an average decrease of 97.3% per quarter

About Orchid Pharma Ltd

Orchid Pharma Ltd. is a globally recognized pharmaceutical company based in Chennai, India, specialized in the development, manufacture and marketing of diverse bulk actives formulations and nutraceuticals. The company’s core expertise covers manufacturing Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms, as well as drug discovery. It is the youngest Indian pharmaceutical company to be awarded the ISO 9002 certification.In 1998 they received approval from the Drug Controller of India (DCI) for the manufacture and export of the main ingredient of Viagra.By 2000 they acquired a manufacturing plant in Aurangabad and in 2004 signed a pact with Par Pharmaceuticals Inc. to market oral cephalosporin formulations in the US market.In 2006 a deal with Biovitrum was signed and two years later the company had approval from the US FDA for their abbreviated new drug application. They entered the Japanese generics market with the creation of awholly owned subsidiary and also inked an agreement with Merck & Co. The company increased their stake in Diakron Pharmaceuticals Inc. up to 76.4 and over the years have made pacts with numerous companies in both drug discovery and commercialization. In 2017 they launched a new product and as of 2020 became a subsidiary of Dhanuka Laboratories Ltd with funding from a special purpose vehicle. Furthermore the company has subscribed to OrBion Pharmaceuticals Pvt. Ltd. and incorporated Orchid BioPharma Ltd, becoming an Associate of the company.

Revenue: ₹207.27Cr as on December 2025 (Q3 FY26)
Net Profit: ₹-12.15Cr as on December 2025 (Q3 FY26)
Listing date: 12 May, 1995
Chairperson Name: Ram Gopal Agarwal
OrganisationOrchid Pharma Ltd
IndustryPharmaceuticals
CEORam Gopal Agarwal
E-voting on sharesClick here to vote

FAQs

What is Orchid Pharma share price today?

Orchid Pharma share price today stands at ₹523.8 as on at the close of the market. Orchid Pharma share today touched a day high of ₹526.4 and a low of ₹498.1.

What is the 52 week high and 52 week low range for Orchid Pharma share?

Orchid Pharma touched a 52 week high of ₹899 and a 52 week low of ₹480. Orchid Pharma share price today i.e. is closed at ₹523.8, which is -41.74% down from its 52 week high and 9.12% up from its 52 week low.

What is Orchid Pharma's market capitalisation today?

Orchid Pharma market capitalisation is ₹2,656.67 Cr as on .

How to buy Orchid Pharma shares?

To buy Orchid Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for ORCHPHARMA or Orchid Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Orchid Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Orchid Pharma trading volume today?

Orchid Pharma trading volume is 1.21L as on . This means that 1.21L shares of Orchid Pharma were bought and sold on the stock market during today's trading session.